PetVivo Holdings, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference

Rhea-AI Summary

PetVivo Holdings (OTCQB: PETV) has announced its participation in the upcoming D. Boral Capital Inaugural Global Conference, scheduled for May 14, 2025, at The Plaza Hotel in New York City. The company's CEO, John Lai, will be available for one-on-one meetings with interested parties from 9:00 A.M. to 3:00 P.M. ET. Investors and stakeholders interested in scheduling meetings can contact John Perez at D. Boral Capital.

Edina, Minnesota--(Newsfile Corp. - May 2, 2025) - PetVivo Holdings, Inc. (OTCQB: PETV) (OTC Pink: PETVW), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.

John Lai, Chief Executive Officer, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. (ET).

To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at jperez@dboralcapital.com.

About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (OTCQB: PETV) (OTC Pink: PETVW) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twenty-one patents protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead products SPRYNG™ with OsteoCushion™ technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.

About D. Boral Capital

D. Boral Capital LLC is an investment bank headquartered in New York which provides advisory and financing solutions to middle market and emerging growth companies. The Company has a proven track record of offering strategic guidance to clients across the globe in any sector, with access to capital from the USA, Asia, Europe, Middle East, and Latin America.

D. Boral Capital is a leader on Wall Street, having aggregated over $25 billion in capital across approximately 350 transactions through various product types.

For further information:
PetVivo Holdings, Inc.
John Lai
612-328-4325
jlai@petvivo.com
www.petvivo.com

Source PetVivo Holdings, Inc.

FAQ

When is PetVivo Holdings (PETV) participating in the D. Boral Capital Conference?

PetVivo Holdings will participate in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City.

Who will represent PETV at the D. Boral Capital Conference 2025?

John Lai, Chief Executive Officer of PetVivo Holdings, will represent the company and host one-on-one meetings.

What are the meeting hours for PETV management at the D. Boral Capital Conference?

One-on-one meetings will be held from 9:00 A.M. to 3:00 P.M. ET on May 14, 2025.

How can investors schedule meetings with PETV management at the conference?

Interested parties should contact John Perez at jperez@dboralcapital.com to register for one-on-one meetings.